KEMRI initiates process to develop COVID-19 vaccine

The Kenya Medical Research Institute (KEMRI) has initiated the process of developing a vaccine for coronavirus.

KEMRI on Tuesday announced that the “candidate vaccine prototype” is likely to be out in October with the cost of production projected to be at Shs. 5oo million.

“All variables constant, the prototype will be ready in the next six months.
Thereafter more laboratory tests will be done with the aim of reaching clinical trials which range from phases one to three,” said a KEMRI official.

This was revealed during a meeting between a team of KEMRI officials led by the agency’s director Yeri Kombe and a seven-member Senate Ad Hoc Committee on coronavirus chaired by Nairobi Senator Johnson Sakaja.